Recent Clinical Observer Group 2026

Students are given opportunity to study a case and write up a talk for the other students:


Students from Nigeria, Pakistan, Mexico, India, Nepal. 2026.


Observers from Turkey, Mexico, USA, Indonesia. April 2026

Observers and medical students from Pakistan, Nigeria Mexico, Peru, Turkey.

Observers watching grand rounds.

Peri-operative Cardiovascular Medication Management for Non-cardiac Surgery.

By Jessica Eve (Java, Indonesia)

REFERENCES

  1. Winchester DE, Mehta JJ, Alexander JT. Perioperative cardiovascular medication
    management for noncardiac surgery. JAMA. Published online March 31, 2026.
    doi:10.1001/jama.2026.0067
  2. American Heart Association. 2024 AHA/ACC guideline for perioperative cardiovascular
    evaluation and management of patients undergoing noncardiac surgery. Circulation.
    2024;150:e351–e442. doi:10.1161/CIR.0000000000001285
  3. Devereaux PJ, Mrkobrada M, Sessler DI, Leslie K, Alonso-Coello P, Kurz A, et al;
    POISE-2 Investigators. Aspirin in patients undergoing noncardiac surgery. N Engl J Med.
    2014;370(16):1494–1503. doi:10.1056/NEJMoa1401105
  4. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, et al; POISE Study
    Group. Effects of extended-release metoprolol succinate in patients undergoing non-
    cardiac surgery (POISE trial): a randomised controlled trial. Lancet.
    2008;371(9627):1839–1847. doi:10.1016/S0140-6736(08)60601-7
  5. Neumann A, Maura G, Weill A, Alla F, Danchin N. Clinical events after discontinuation of
    β-blockers in patients without heart failure optimally treated after acute myocardial
    infarction: a cohort study on the French healthcare databases. Circ Cardiovasc Qual
    Outcomes. 2018;11(4):e004356. doi:10.1161/CIRCOUTCOMES.117.004356
  6. Lindenauer PK, Pekow P, Wang K, et al. Lipid-lowering therapy and in-hospital
    mortality following major noncardiac surgery. JAMA. 2004;291(17):2092-2099.
    doi:10.1001/jama.291.17.2092
  7. London MJ, Schwartz GG, Hur K, Henderson WG. Association of perioperative
    statin use with mortality and morbidity after major noncardiac surgery. JAMA Intern
    Med. 2017;177(2):231-242. doi:10.1001/jamainternmed.2016.8005
  8. Berwanger O, de Barros E Silva PG, Barbosa RR, et al. Atorvastatin for high-
    risk statin-naïve patients undergoing noncardiac surgery. Am Heart J. 2017;184:88-
  9. doi:10.1016/j.ahj.2016.11.001
  10. Graham MM, Sessler DI, Parlow JL, et al. Aspirin in patients with previous
    percutaneous coronary intervention undergoing noncardiac surgery. Ann Intern Med.
    2018;168(4):237-244. doi:10.7326/M17-2341
  11. Kobori T, Onishi Y, Yoshida Y, et al. Association of glucagon-like peptide-1
    receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy.
    J Diabetes Investig. 2023;14(6):767-773. doi:10.1111/jdi.14005
  12. Joshi GP, LaMasters T, Kindel TL. Preprocedure care of patients on glucagon-
    like peptide-1 receptor agonists. Anesthesiology. 2024;141(6):1208-1209.
    doi:10.1097/ALN.0000000000005231